Zyngenia, Inc Information
Contact top employees from
Zyngenia, Inc
Summary
Zyngenia, Inc is a private company that has been in the industry for 16 years. The company currently specializes in the Biotechnology, Biotechnology areas. The position of the CEO is occupied by Andrey Kolokoltsov. Its headquarters is located at Washington, District of Columbia, USA. The number of employees ranges from 1 to 25. The annual revenue of Zyngenia, Inc varies between 5.0M and 25M. Total funding of the company - $43M. To connect with Zyngenia, Inc employee register on SignalHire.
Industries
Biotechnology
Headquarters Location
Employees Size
10-50 employees
Specialties
Single-Protein Combination Therapeutics
SIC Code
2836
DMA Code
Washington Metropolitan Area
Founded
2009
Estimated Annual Revenue
$5.0M - 25M
Operating Status
Independent Company
Competitors
Founded | Type | Employees | Revenue | Funding | |
---|---|---|---|---|---|
2000 | Privately Held | 25 - 100 | 4.1M | $3M | |
2008 | Public Company | 100 - 250 | 64M | $302.6M | |
1996 | Public Company | 25 - 100 | < 1M | $160M | |
2003 | Privately Held | 25 - 100 | 5M | $58.4M | |
- | Privately Held | 100 - 250 | 37.3M | $0 | |
1977 | - | 100 - 250 | 31.7M | $0 | |
2009 | - | 100-200 | - | $- |
Employees Turnover 3 quarter 2025
Length of Employment
Employee tenure at Zyngenia, Inc shows a diverse range of experience levels:
22% for 8–10 years78% have over 11 years of service at Zyngenia, IncContact top employees from
Zyngenia, Inc
Carlos Barbas
Founder
Dan Crossan
Research Associate GLP Assay Development
Carlos Barbas
Founder
barrack minna
Costumer support
thomas ahrens
Cook
Geping Wang
Associate Scientist
Mike Hayes
HR Coordinator
Xiaotao Yao
scientist
Similar Companies
FAQ
Zyngenia, Inc operates in the Biotechnology industries. More details can be found on the official website: zyngenia.com.
The headquarters of Zyngenia, Inc are located in Gaithersburg, United States.
The current CEO of Zyngenia, Inc is Andrey Kolokoltsov
Zyngenia, Inc currently employs 10-50 people.
Zyngenia, Inc's revenue is approximately 5M.
Well-known competitors of Zyngenia, Inc include Parion Sciences, G1 Therapeutics, Inc., Endocyte and Atox Bio.